RNDr. Ludmila Šebejová, Ph.D.
Head, Biobank and CELSPAC Laboratories
Correspondence Address:
Kotlářská 267/2, 611 37 Brno
Office: bldg. D29/1S118
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7637 |
---|---|
E‑mail: |
Total number of publications: 76
2024
-
Exposure to benzotriazoles and benzothiazoles in Czech male population and its associations with biomarkers of liver function, serum lipids and oxidative stress
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, year: 2024, DOI
2023
-
Longitudinal study of epigenetic aging and its relationship with brain aging and cognitive skills in young adulthood
frontiers in aging neuroscience, year: 2023, volume: 15, edition: August 2023, DOI
-
The exposure of Czech firefighters to perfluoroalkyl substances and polycyclic aromatic hydrocarbons: CELSPAC – FIREexpo case-control human biomonitoring study
SCIENCE OF THE TOTAL ENVIRONMENT, year: 2023, volume: 881, edition: July 2023, DOI
2019
-
Distinct cellular responses to replication stress leading to apoptosis or senescence
FEBS Open Bio, year: 2019, volume: 9, edition: 5, DOI
2017
2015
-
Chronic lymphocytic leukemia cells are highly susceptible to direct inhibition of checkpoint kinase
Year: 2015, type: Conference abstract
-
Mutační a funkční analýza genu ATM u pacientů s chronickou lymfocytární leukémií
Year: 2015, type: Conference abstract
-
Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study
American Journal of Hematology, year: 2015, volume: 90, edition: 5, DOI
2014
-
Distinct in vitro sensitivity of p53-mutated and ATM-mutated chronic lymphocytic leukemia cells to ofatumumab and rituximab
Experimental Hematology, year: 2014, volume: 42, edition: 10, DOI
-
Is checkpoint kinase 1 a suitable molecular target for combination with cancer chemotherapeutics?
Year: 2014, type: Conference abstract